Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis.

ABSTRACT: Professional society guidelines recommend semiannual screening for hepatocellular carcinoma (HCC) in patients with cirrhosis; however, studies suggest underuse of screening in clinical practice. Our study's aim was to characterize reasons for HCC screening underuse among patients with cirrhosis. We conducted a retrospective cohort study of patients with cirrhosis diagnosed with HCC in two large health systems from 2011 to 2019. We classified screening receipt as consistent, inconsistent, or no screening in the year before HCC diagnosis. We categorized reasons for screening underuse as a potential failure at each of the following steps required for HCC screening: receipt of regular outpatient care, recognition of liver disease, recognition of cirrhosis, screening orders in patients with cir

SUBMITTER: Marquardt P 

PROVIDER: S-EPMC8435280 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature